Ventricular conduction stability test: a method to identify and quantify changes in whole heart activation patterns during physiological stress.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 10 07 2018
accepted: 02 02 2019
pubmed: 2 3 2019
medline: 15 12 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Abnormal rate adaptation of the action potential is proarrhythmic but is difficult to measure with current electro-anatomical mapping techniques. We developed a method to rapidly quantify spatial discordance in whole heart activation in response to rate cycle length changes. We test the hypothesis that patients with underlying channelopathies or history of aborted sudden cardiac death (SCD) have a reduced capacity to maintain uniform activation following exercise. Electrocardiographical imaging (ECGI) reconstructs >1200 electrograms (EGMs) over the ventricles from a single beat, providing epicardial whole heart activation maps. Thirty-one individuals [11 SCD survivors; 10 Brugada syndrome (BrS) without SCD; and 10 controls] with structurally normal hearts underwent ECGI vest recordings following exercise treadmill. For each patient, we calculated the relative change in EGM local activation times (LATs) between a baseline and post-exertion phase using custom written software. A ventricular conduction stability (V-CoS) score calculated to indicate the percentage of ventricle that showed no significant change in relative LAT (<10 ms). A lower score reflected greater conduction heterogeneity. Mean variability (standard deviation) of V-CoS score over 10 consecutive beats was small (0.9 ± 0.5%), with good inter-operator reproducibility of V-CoS scores. Sudden cardiac death survivors, compared to BrS and controls, had the lowest V-CoS scores post-exertion (P = 0.011) but were no different at baseline (P = 0.50). We present a method to rapidly quantify changes in global activation which provides a measure of conduction heterogeneity and proof of concept by demonstrating SCD survivors have a reduced capacity to maintain uniform activation following exercise.

Identifiants

pubmed: 30820561
pii: 5366944
doi: 10.1093/europace/euz015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1422-1431

Subventions

Organisme : British Heart Foundation
ID : FS/14/27/30752
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/10/38/28268
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/20/31339
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/13/30619
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/16/3/32175
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/15/25/31423
Pays : United Kingdom

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Matthew J Shun-Shin (MJ)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Kevin M W Leong (KMW)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Fu Siong Ng (FS)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Nicholas W F Linton (NWF)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Zachary I Whinnett (ZI)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Michael Koa-Wing (M)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Norman Qureshi (N)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

David C Lefroy (DC)

Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Sian E Harding (SE)

National Heart & Lung Institute, Imperial College London, London, UK.

Phang Boon Lim (PB)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Nicholas S Peters (NS)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Darrel P Francis (DP)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Amanda M Varnava (AM)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Prapa Kanagaratnam (P)

National Heart & Lung Institute, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, Du Cane Road, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH